From Bioreactor to Clinic: Scaling Up Extracellular Vesicle Manufacturing for Therapeutic Use

[Article Title]

Manufacturing extracellular vesicles at clinical scale presents significant downstream processing challenges. This application note describes how an integrated TFDF and TFF platform replaces traditional centrifugation with a fully closed, GMP-ready workflow, delivering high recovery yields and reproducible results from lab development through 200+ liter scale.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.